Earnings Call · Q1 FY2021·2021-05-13

Q1 21EPS +17.65%·Rev n/aQ4 20EPS +5.26%·Rev n/aQ3 20EPS -64.29%·Rev n/aQ2 20EPS +17.39%·Rev n/a⚠ consensus missing

PDS Biotechnology Corp PDSB

Deanne Randolph — Unknown

Frank Bedu-Addo — Chief Executive Officer

Lauren Wood — Chief Medical Officer

Seth Van Voorhees — Chief Financial Officer

+1.8%1d on move date3d+11.6%5d+30.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PDSB calls or request research access.

More PDSB calls Browse calls Request research access